Gastrodin: An ancient Chinese herbal medicine as a source for anti-osteoporosis agents via reducing reactive oxygen species

Bone

Volumn 73, Issue , 2015, Pages 132-144

  Huang, Qiang ^a   Shi, Jun ^a   Gao, Bo ^a   Zhang, Hong Yang ^a   Fan, Jing ^a   Li, Xiao Jie ^a   Fan, Jin Zhu ^a   Han, Yue Hu ^a   Zhang, Jin Kang ^b   Yang, Liu ^a   Luo, Zhuo Jing ^a   Liu, Jian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Gastrodin; Human bone marrow mesenchymal stem cell; Osteoporosis; RAW264.7 cell; Reactive oxygen species

Indexed keywords

BIOLOGICAL MARKER; GASTRODIN; HYDROGEN PEROXIDE; INTERLEUKIN 6; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN CTX 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; BENZYL ALCOHOL DERIVATIVE; GLUCOSIDE; HERBACEOUS AGENT; TNFSF11 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOSTEOPOROSIS ACTIVITY; ARTICLE; BONE DEFECT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROPHAGE; MINERAL APPOSITION RATE; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRABECULAR BONE; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECTS; METABOLISM; OVARIECTOMY;

ANIMALS; BENZYL ALCOHOLS; CELL DIFFERENTIATION; CELL LINE; DRUGS, CHINESE HERBAL; FEMALE; GLUCOSIDES; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; OSTEOPOROSIS; OVARIECTOMY; RANK LIGAND; REACTIVE OXYGEN SPECIES;

EID: 84922706643     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.12.059     Document Type: Article

References (59)

1. Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: now and the future. Lancet 2011, 377:1276-1287.
2. Almeida M., Han L., Martin-Millan M., O'Brien C.A., Manolagas S.C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting -catenin from T cell factor- to Forkhead box O-mediated transcription. J Biol Chem 2007, 37:27298-27305.
3. Sanchez-Rodriguez M.A., Ruiz-Ramos M., Correa-Munoz E., Mendoza-Nunez V.M. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007, 8:124.
4. Manolagas S.C. From oestrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 2010, 31:266-300.
5. Sendur O.F., Turan Y., Tastaban E., Serter M. Antioxidant status in patients with osteoporosis: a controlled study. Joint Bone Spine 2009, 76:514-518.
6. Ozgocmen S., Kaya H., Fadillioglu E., Aydogan R., Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007, 295:45-52.
7. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304.
8. Muthusami S., Ramachandran I., Muthusamy B., Vasudevan G., Prabhu V., Subramaniam V., et al. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta 2005, 360:81-86.
9. 2 while making cholesterol. Endocrinology 2008, 149:3264-3266.
10. Li N., Lee W.Y., Lin S.E., Ni M., Zhang T., Huang X.R., et al. Partial loss of Smad7 function impairs bone remodeling, osteogenesis and enhances osteoclastogenesis in mice. Bone 2014, 67:46-55.
11. Soltanoff C.S., Yang S., Chen W., Li Y.P. Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr 2009, 19:1-46.
12. Li Z., Kong K., Qi W. Osteoclast and its roles in calcium metabolism and bone development and remodeling. Biochem Biophys Res Commun 2006, 343:345-350.
13. Lee N.K., Choi Y.G., Baik J.Y., Han S.Y., Jeong D.W., Bae Y.S., et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106:852-859.
14. Arai M., Shibata Y., Pugdee K., Abiko Y., Ogata Y. Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 2007, 59:27-33.
15. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
16. Kim W.K., Meliton V., Bourquard N., Hahn T.J., Parhami F. Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress. J Cell Biochem 2010, 111(5):1199-1209.
17. Justesen J., Stenderup K., Ebbesen E.N., Mosekilde L., Steiniche T., Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001, 2:165-171.
18. Syed F.A., Oursler M.J., Hefferanm T.E., Peterson J.M., Riggs B.L., Khosla S. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int 2008, 19:1323-1330.
19. Almeida M., Han L., Martin-Millan M., Plotkin L.I., Stewart S.A., Roberson P.K., et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 2007, 282:27285-27297.
20. Jilka R.L., Almeida M., Ambrogini E., Han L., Roberson P.K., Weinstein R.S., et al. Decreased oxidative stress and greater bone anabolism in the aged, as compared to the young, murine skeleton by parathyroid hormone. Aging Cell 2010, 9:851-867.
21. Mukwaya E., Xu F., Wong M.S., Zhang Y. Chinese herbal medicine for bone health. Pharm Biol 2014, 52(9):1223-1228.
22. Jiang G.L., Wu H.Y., Hu Y.Q., Li J., Li Q.L. Gastrodin inhibits glutamate-induced apoptosis of PC12 cells via inhibition of CaMKII/ASK-1/p38 MAPK/p53 signaling cascade. Cell Mol Neurobiol 2014, 34:591-602.
23. Yang X.D., Zhu J., Yang R., Liu J.P., Li L., Zhang H.B. Phenolic constituents from the rhizomes of Gastrodia elata. Nat Prod Res 2007, 21:180-186.
24. Hayashi J., Sekine T., Deguchi S., Lin Q., Horie S., Tsuchiya S., et al. Phenolic compounds from Gastrodia rhizome and relaxant effects of related compounds on isolated smooth muscle preparation. Phytochemistry 2002, 59:513.
25. Kim H.J., Moon K.D., Lee D.S., Lee S.H. Ethyl ether fraction of Gastrodia elata Blume protects amyloid b peptide-induced cell death. Ethnopharmacol 2003, 84:95.
26. Hsieh C.L., Lin J.J., Chiang S.Y., Su S.Y., Tang N.Y., Lin G.G., et al. Gastrodia elata modulated activator protein 1 via c-Jun N-terminal kinase signaling pathway in kainic acid-induced epilepsy in rats. J Ethnopharmacol 2007, 109:241.
27. Shu C., Chen C., Zhang D.P., Guo H., Zhou H., Zong J., et al. Gastrodin protects against cardiac hypertrophy and fibrosis. Mol Cell Biochem 2012, 359:9-16.
28. Yong W., Xing T.R., Wang S., Chen L., Hu P., Li C.C., et al. Protective effects of gastrodin on lead-induced synaptic plasticity deficits in rat hippocampus. Planta Med 2009, 75:1112-1117.
29. Song Y.T., Tang Y.P., Hong Q.T. Protection of traditional Chinese medicine Kangdai I against cerebral cortex neuron jury induced by simulated brain ischemia and reperfusion in vitro. Chin J Clin Rehabil 2004, 8:1375-1377.
30. Yu S.J., Kim J.R., Lee C.K., Han J.E., Lee J.H., Kim H.S., et al. Gastrodia elata Blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions. Biol Pharm Bull 2005, 28:1016-1020.
31. Zhang J.K., Yang L., Meng G.L., Fan J., Chen J.Z., He Q.Z., et al. Protective effect of tetrahydroxystilbene glucoside against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells. Eur J Pharmacol 2012, 689:31-37.
32. Sharma P., Patntirapong S., Hann S., Hauschka P.V. RANKL-RANK signaling regulates expression of xenotropic and polytropic virus receptor (XPR1) in osteoclasts. Biochem Biophys Res Commun 2010, 399:129-132.
33. Chiang H.M., Chen H.C., Lin T.J., Shih I.J., Wen K.C. Michelia alba extract attenuates UVB-induced expression of matrix metalloproteinases via MAP kinase pathway in human dermal fibroblast. Food Chem Toxicol 2012, 50:4250-4269.
34. Wang X., Harimoto K., Liu J., Guo J., Hinshaw S., Chang Z., et al. Spata4 promotes osteoblast differentiation through Erk-activated Runx2 pathway. J Bone Miner Res 2011, 26:1964-1973.
35. Chen J.J., Zhang N.F., Mao G.X., He X.B., Zhan Y.C., Deng H.B., et al. Salidroside stimulates osteoblast differentiation through BMP signaling pathway. Food Chem Toxicol 2013, 62:499-505.
36. Zhang J.K., Yang L., Meng G.L., Yuan Z., Fan J., Li D., et al. Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators. PLoS One 2013, 8(2):e57251.
37. Dempster D.W., Compston J.E., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2013, 28(1):2-17.
38. Liu C.C., Sherrard D.J., Maloney N.A., Howard G.A. Reactivation of inhibited bone acid phosphatase and its significance in bone histomorphometry. J Histochem Cytochem 1987, 35(12):1355-1363.
39. Hernández-García D., Wood C.D., Castro-Obregón S., Covarrubias L. Reactive oxygen species: a radical role in development?. Free Radic Biol Med 2010, 49:130-143.
40. Adam-Vizi V., Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 2006, 27(12):639-645.
41. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Catani M., et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003, 88:1523-1527.
42. Baek K.H., Oh K.W., Lee W.Y., Lee S.S., Kim M.K., Kwon H.S., et al. Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 2010, 87:226-235.
43. Denisova N.A., Cantuti-Castelvetri I., Hassan W.N., Paulson K.E., Joseph J.A. Role of membrane lipids in regulation of vulnerability to oxidative stress in PC12 cells: implication for aging. Free Radic Biol Med 2001, 30:671-678.
44. Liu A.L., Zhang Z.M., Zhu B.F., Liao Z.H., Liu Z. Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Cell Biol Int 2004, 28:905-911.
45. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol Rev 1998, 78:783-809.
46. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
47. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
48. Bai X.C., Lu D., Liu A.L., Zhang Z.M., Li X.M., Zou Z.P., et al. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 2005, 280:17497-17506.
49. Papanicolaou D.A., Vgontzas A.N. Interleukin-6: the endocrine cytokine. J Clin Endocrinol Metab 2000, 85:1331-1333.
50. Kitazawa R., Kimble R.B., Vannice J.L., Kung V.T., Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994, 94:2397-2406.
51. Cummings S.R., Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359:1761-1767.
52. Mohamed S.G., Sugiyama E., Shinoda K., Taki H., Hounoki H., Abdel-Aziz H.O., et al. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Bone 2007, 41:592-602.
53. Anusaksathien O., Laplace C., Li X., Ren Y., Peng L., Goldring S.R., et al. Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene. J Biol Chem 2001, 276:22663-22674.
54. Motyckova G., Weilbaecher K., Horstmann M., Rieman D., Fisher D. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A 2001, 98:5798-5803.
55. Reddy S., Hundley J., Windle J., Alcantara O., Linn R., Leach R., et al. Characterization of the mouse tartrate-resistant acid phosphatase (trap) gene promoter. J Bone Miner Res 1995, 10:601-606.
56. Choi H.J., Park Y.R., Nepal M., Choi B.Y., Cho N.P., Choi S.H., et al. Inhibition of osteoclastogenic differentiation by ikarisoside A in RAW 264.7 cells via JNK and NF-jB signaling pathways. Eur J Pharmacol 2010, 636:28-35.
57. Estrela J.M., Ortega A., Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 2006, 43:143-181.
58. Chappard D., Basle M.F., Legrand E., Audran M. Trabecular bone microarchitecture: a review. Morphologie 2008, 92:162-170.
59. Ferreri S.L., Talish R., Trandafir T., Qin Y.X. Mitigation of bone loss with ultrasound induced dynamic mechanical signals in an OVX induced rat model of osteopenia. Bone 2011, 48:1095-1102.